AFP and neoplasm: The diversity in patient populations, tumor biology (e.g., MVI and AFP levels), underlying liver conditions (e.g., cirrhosis vs. non-cirrhosis), and surgical approaches (AR vs. NAR) limits the ability to draw uniform conclusions.